9 October 2020 - The Australian Government has given approval to proceed with two measures to enhance transparency for prescription ...
7 October 2020 - The FDA has laid out its safety standards for developers of COVID-19 vaccines after the White House ...
6 October 2020 - Confirmed 1 October 2020 prices resulting from the 2020 October Cycle of Price Disclosure has now been ...
5 October 2020 - The EMA has re-affirmed today that it will uphold its long-standing commitment to independence and transparency ...
29 September 2020 - The FDA has issued a number of contentious decisions during the COVID-19 pandemic related to investigational ...
24 September 2020 - The chief executive of AstraZeneca has said the public must trust that multiple regulators will review ...
22 September 2020 - The level of trust in health economics and outcomes research studies has been an on-going concern owing ...
1 September 2020 - Less than one week in and the agenda for the next scheduled PBAC meeting has already been ...
25 August 2020 - Agenda items are revised with no indication of what has been changed. ...
20 August 2020 - A proposed change to the new health insurance law that seeks to keep drug prices under lock ...
6 August 2020 - Amid growing clamour for more transparency from the pharmaceutical industry, Italy has become the first country ...
5 August 2020 - A letter signed by nearly 400 health experts asked the agency to use its vaccine advisory panel ...
28 July 2020 - Indicative 1 October 2020 prices resulting from the 2020 October Cycle of Price Disclosure have now been ...
23 July 2020 - The PBAC has made a statement outlining its support for measures to improve the transparency of ...
25 June 2020 - The summary of price disclosure price reductions for the October 2020 Cycle has now been published. ...